Targeting apoptosis in autoimmune hepatitis (Q38231217)

31 August 2017

title

Targeting apoptosis in autoimmune hepatitis (English)

1 reference

31 August 2017

1 reference

Albert J Czaja

1

1 reference

31 August 2017

publication date

20 July 2014

1 reference

Digestive Diseases and Sciences

31 August 2017

published in

1 reference

31 August 2017

volume

59

1 reference

31 August 2017

issue

12

1 reference

31 August 2017

page(s)

2890-2904

1 reference

Diagnosis and management of autoimmune hepatitis

31 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1007/S10620-014-3284-2

The nature of piecemeal necrosis in chronic active hepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S10620-014-3284-2

Autoimmune hepatitis. Part A: pathogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S10620-014-3284-2

Apoptosis: A Basic Biological Phenomenon with Wideranging Implications in Tissue Kinetics

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S10620-014-3284-2

Shrinkage necrosis: a distinct mode of cellular death.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S10620-014-3284-2

Chromatin cleavage in apoptosis: association with condensed chromatin morphology and dependence on macromolecular synthesis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S10620-014-3284-2

Apoptosis-associated antigens recognized by autoantibodies in patients with the autoimmune liver disease primary biliary cirrhosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S10620-014-3284-2

Dephosphorylation of autoantigenic ribosomal P proteins during Fas-L induced apoptosis: a possible trigger for the development of the autoimmune response in patients with systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S10620-014-3284-2

Autoantigens in systemic autoimmunity: critical partner in pathogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S10620-014-3284-2

Corpse clearance defines the meaning of cell death

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S10620-014-3284-2

Cues for apoptotic cell engulfment: eat-me, don't eat-me and come-get-me signals

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S10620-014-3284-2

Apoptotic cell removal in development and tissue homeostasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S10620-014-3284-2

Apoptotic cells promote their own clearance and immune tolerance through activation of the nuclear receptor LXR.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S10620-014-3284-2

Mitochondria and apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S10620-014-3284-2

21 January 2018

Apoptosis and the liver

1 reference

https://api.crossref.org/works/10.1007/S10620-014-3284-2

Phagocytosis of apoptotic bodies by hepatic stellate cells induces NADPH oxidase and is associated with liver fibrosis in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S10620-014-3284-2

Apoptotic pathways in primary biliary cirrhosis and autoimmune hepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S10620-014-3284-2

Apoptosis and the liver: relation to autoimmunity and related conditions

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S10620-014-3284-2

Apoptosis: clinical relevance and pharmacological manipulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S10620-014-3284-2

The apoptosome: emerging insights and new potential targets for drug design

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S10620-014-3284-2

Apoptosis in diseases of the liver

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S10620-014-3284-2

Liver restores immune homeostasis after local inflammation despite the presence of autoreactive T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S10620-014-3284-2

The coordinate release of cytochrome c during apoptosis is rapid, complete and kinetically invariant

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S10620-014-3284-2

Mitochondrial membrane permeability transition and cell death

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S10620-014-3284-2

The Bcl-2 protein family: arbiters of cell survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S10620-014-3284-2

Mitochondrial membrane permeabilization in cell death

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S10620-014-3284-2

BID, BIM, and PUMA Are Essential for Activation of the BAX- and BAK-Dependent Cell Death Program

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S10620-014-3284-2

Apaf-1 and caspase-9 accelerate apoptosis, but do not determine whether factor-deprived or drug-treated cells die

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S10620-014-3284-2

Caspase-9 and APAF-1 form an active holoenzyme

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S10620-014-3284-2

Apoptosis as a Mechanism for Liver Disease Progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S10620-014-3284-2

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S10620-014-3284-2

Inducible dimerization and inducible cleavage reveal a requirement for both processes in caspase-8 activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S10620-014-3284-2

The CD95(APO-1/Fas) DISC and beyond

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S10620-014-3284-2

The protein structures that shape caspase activity, specificity, activation and inhibition

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S10620-014-3284-2

Assembly of the Bak apoptotic pore: a critical role for the Bak protein α6 helix in the multimerization of homodimers during apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S10620-014-3284-2

Structure and chromosome localization of the human CASP8 gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S10620-014-3284-2

Caspase-10 is an initiator caspase in death receptor signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S10620-014-3284-2

Individual caspase-10 isoforms play distinct and opposing roles in the initiation of death receptor-mediated tumour cell apoptosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S10620-014-3284-2

Death receptor recruitment of endogenous caspase-10 and apoptosis initiation in the absence of caspase-8

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S10620-014-3284-2

Caspase-10 is recruited to and activated at the native TRAIL and CD95 death-inducing signalling complexes in a FADD-dependent manner but can not functionally substitute caspase-8.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S10620-014-3284-2

Activation and specificity of human caspase-10.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S10620-014-3284-2

Apoptosis in immune-mediated liver diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S10620-014-3284-2

Hepatic inflammation and progressive liver fibrosis in chronic liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S10620-014-3284-2

Review article: chemokines as orchestrators of autoimmune hepatitis and potential therapeutic targets

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S10620-014-3284-2

Apoptosis: the nexus of liver injury and fibrosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S10620-014-3284-2

Cytokeratin 18-based modification of the MELD score improves prediction of spontaneous survival after acute liver injury.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S10620-014-3284-2

Protection from Fas-mediated apoptosis by a soluble form of the Fas molecule

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S10620-014-3284-2

Modulation of apoptosis as a target for liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S10620-014-3284-2

Fas polymorphisms influence susceptibility to autoimmune hepatitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S10620-014-3284-2

Assignment of the human Fas antigen gene (Fas) to 10q24.1

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S10620-014-3284-2

T cell immunity in autoimmune hepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S10620-014-3284-2

Understanding alternative splicing: towards a cellular code

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S10620-014-3284-2

Elevated serum levels of soluble Fas/APO-1 (CD95) in patients with hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S10620-014-3284-2

Apoptosis (the 1992 Frank Rose Memorial Lecture).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S10620-014-3284-2

Liver NK cells expressing TRAIL are toxic against self hepatocytes in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S10620-014-3284-2

Major histocompatibility complex class I-related chains A and B (MIC A/B): a novel role in nonalcoholic steatohepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S10620-014-3284-2

Diversity and characterization of polymorphic 5' promoter haplotypes of MICA and MICB genes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S10620-014-3284-2

Analysis of the composition, assembly kinetics and activity of native Apaf-1 apoptosomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S10620-014-3284-2

Caspase-independent cell death and mitochondrial disruptions observed in the Apaf1-deficient cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S10620-014-3284-2

Structure of the apoptotic protease-activating factor 1 bound to ADP

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S10620-014-3284-2

The apoptosome activates caspase-9 by dimerization

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S10620-014-3284-2

Negative regulation of cytochrome c-mediated oligomerization of Apaf-1 and activation of procaspase-9 by heat shock protein 90

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S10620-014-3284-2

Negative regulation of the Apaf-1 apoptosome by Hsp70

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S10620-014-3284-2

Death versus survival: functional interaction between the apoptotic and stress-inducible heat shock protein pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S10620-014-3284-2

Intracellular nucleotides act as critical prosurvival factors by binding to cytochrome C and inhibiting apoptosome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S10620-014-3284-2

Human caspases: activation, specificity, and regulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S10620-014-3284-2

Targeting XIAP for the treatment of malignancy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S10620-014-3284-2

Human inhibitor of apoptosis proteins: why XIAP is the black sheep of the family

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S10620-014-3284-2

TUCAN, an antiapoptotic caspase-associated recruitment domain family protein overexpressed in cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S10620-014-3284-2

A novel isoform of TUCAN is overexpressed in human cancer tissues and suppresses both caspase-8- and caspase-9-mediated apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S10620-014-3284-2

HtrA2 promotes cell death through its serine protease activity and its ability to antagonize inhibitor of apoptosis proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S10620-014-3284-2

Reduced expression of the inhibitor of apoptosis proteins in T cells from patients with multiple sclerosis following interferon-beta therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S10620-014-3284-2

Elevated Bcl-X(L) levels correlate with T cell survival in multiple sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S10620-014-3284-2

Disease activity in multiple sclerosis correlates with T lymphocyte expression of the inhibitor of apoptosis proteins.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S10620-014-3284-2

Overexpression of the apoptosis inhibitor FLIP in T cells correlates with disease activity in multiple sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S10620-014-3284-2

Cellular FLICE-inhibitory protein (c-FLIP) signalling: a key regulator of receptor-mediated apoptosis in physiologic context and in cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S10620-014-3284-2

c-FLIP maintains tissue homeostasis by preventing apoptosis and programmed necrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S10620-014-3284-2

Defective function of Fas in T cells from paediatric patients with autoimmune thyroid diseases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S10620-014-3284-2

Mechanisms of hepatic fibrogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S10620-014-3284-2

Review article: The prevention and reversal of hepatic fibrosis in autoimmune hepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S10620-014-3284-2

A blast from the past: clearance of apoptotic cells regulates immune responses.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S10620-014-3284-2

Fas enhances fibrogenesis in the bile duct ligated mouse: a link between apoptosis and fibrosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S10620-014-3284-2

The Caspase Inhibitor IDN-6556 Attenuates Hepatic Injury and Fibrosis in the Bile Duct Ligated Mouse

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S10620-014-3284-2

Hepatocyte-specific disruption of Bcl-xL leads to continuous hepatocyte apoptosis and liver fibrotic responses.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S10620-014-3284-2

Macrophage receptors and immune recognition

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S10620-014-3284-2

The role of phospholipid oxidation products in inflammatory and autoimmune diseases: evidence from animal models and in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S10620-014-3284-2

Identification of a factor that links apoptotic cells to phagocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S10620-014-3284-2

Engulfment of apoptotic cells: signals for a good meal

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S10620-014-3284-2

TAM receptors and the clearance of apoptotic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S10620-014-3284-2

Reciprocal regulation of inflammation and lipid metabolism by liver X receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S10620-014-3284-2

Nuclear receptors in macrophage biology: at the crossroads of lipid metabolism and inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S10620-014-3284-2

Human intrahepatic biliary epithelial cells engulf blebs from their apoptotic peers

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S10620-014-3284-2

Nucleotides released by apoptotic cells act as a find-me signal to promote phagocytic clearance

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S10620-014-3284-2

Expression of P2Y nucleotide receptors and ectonucleotidases in quiescent and activated rat hepatic stellate cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S10620-014-3284-2

Autoimmunity and the clearance of dead cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S10620-014-3284-2

Contextual regulation of inflammation: a duet by transforming growth factor-beta and interleukin-10.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S10620-014-3284-2

Apoptosis: the quiet death silences the immune system

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S10620-014-3284-2

Structure-based design, synthesis, and evaluation of conformationally constrained mimetics of the second mitochondria-derived activator of caspase that target the X-linked inhibitor of apoptosis protein/caspase-9 interaction site.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S10620-014-3284-2

Bcl-2 antisense (oblimersen sodium) plus dacarbazine in patients with advanced melanoma: the Oblimersen Melanoma Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S10620-014-3284-2

Randomized phase III trial of fludarabine plus cyclophosphamide with or without oblimersen sodium (Bcl-2 antisense) in patients with relapsed or refractory chronic lymphocytic leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S10620-014-3284-2

Caspase inhibitors for the treatment of hepatitis C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S10620-014-3284-2

Orally-administered caspase inhibitor PF-03491390 is retained in the liver for prolonged periods with low systemic exposure, exerting a hepatoprotective effect against alpha-fas-induced liver injury in a mouse model

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S10620-014-3284-2

Pan-caspase inhibitor VX-166 reduces fibrosis in an animal model of nonalcoholic steatohepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S10620-014-3284-2

Impact of pan-caspase inhibition in animal models of established steatosis and non-alcoholic steatohepatitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S10620-014-3284-2

Improvement of the survival rate after rat massive hepatectomy due to the reduction of apoptosis by caspase inhibitor.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S10620-014-3284-2

Caspases as drug targets in ischemic organ injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S10620-014-3284-2

Oral IDN-6556, an antiapoptotic caspase inhibitor, may lower aminotransferase activity in patients with chronic hepatitis C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S10620-014-3284-2

Low doses of the novel caspase-inhibitor GS-9450 leads to lower caspase-3 and -8 expression on peripheral CD4 and CD8 T-cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S10620-014-3284-2

Emerging roles of TLR7 and TLR9 in murine SLE.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S10620-014-3284-2

Classification, mechanisms of action, and therapeutic applications of inhibitory oligonucleotides for Toll-like receptors (TLR) 7 and 9.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S10620-014-3284-2

Inhibitor of apoptosis proteins (IAPs) as regulatory factors of hepatic apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S10620-014-3284-2

XIAP: apoptotic brake and promising therapeutic target.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S10620-014-3284-2

XIAP discriminates between type I and type II FAS-induced apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S10620-014-3284-2

Inhibitor of apoptosis proteins as novel targets in inflammatory processes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S10620-014-3284-2

Importance of nucleotide sequence and chemical modifications of antisense oligonucleotides

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S10620-014-3284-2

Downregulation of xIAP expression by small interfering RNA inhibits cellular viability and increases chemosensitivity to methotrexate in human hepatoma cell line HepG2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S10620-014-3284-2

Contribution of histidine-rich glycoprotein in clearance of immune complexes and apoptotic cells: implications for ameliorating autoimmune diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S10620-014-3284-2

Novel mechanisms for antisense-mediated regulation of gene expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S10620-014-3284-2

Short interfering RNA targetting NF-kappa B induces apoptosis of hepatic stellate cells and attenuates extracellular matrix production

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S10620-014-3284-2

Death receptor Fas and autoimmune disease: from the original generation to therapeutic application of agonistic anti-Fas monoclonal antibody

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S10620-014-3284-2

Peptides and peptide mimics as modulators of apoptotic pathways.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S10620-014-3284-2

Amelioration of autoimmune neuroinflammation by the fusion molecule Fn14·TRAIL

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S10620-014-3284-2

Engagement of the PD-1 immunoinhibitory receptor by a novel B7 family member leads to negative regulation of lymphocyte activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S10620-014-3284-2

PD-L2 is a second ligand for PD-1 and inhibits T cell activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S10620-014-3284-2

The function of programmed cell death 1 and its ligands in regulating autoimmunity and infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S10620-014-3284-2

Costimulating aberrant T cell responses by B7-H1 autoantibodies in rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S10620-014-3284-2

Role of the JNK Pathway in Human Diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S10620-014-3284-2

JNK activation is required for TNFα-induced apoptosis in human hepatocarcinoma cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S10620-014-3284-2

A murine model of type 2 autoimmune hepatitis: Xenoimmunization with human antigens

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S10620-014-3284-2

Breaking tolerance to the natural human liver autoantigen cytochrome P450 2D6 by virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S10620-014-3284-2

Prevention of hepatocellular carcinoma development associated with chronic hepatitis by anti-fas ligand antibody therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S10620-014-3284-2

Mice deficient for the 55 kd tumor necrosis factor receptor are resistant to endotoxic shock, yet succumb to L. monocytogenes infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S10620-014-3284-2

Apoptosis as a mechanism for cell surface expression of the autoantigen pyruvate dehydrogenase complex.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S10620-014-3284-2

Apotopes and the biliary specificity of primary biliary cirrhosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S10620-014-3284-2

Biliary apotopes and anti-mitochondrial antibodies activate innate immune responses in primary biliary cirrhosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S10620-014-3284-2

Epithelial cell specificity and apotope recognition by serum autoantibodies in primary biliary cirrhosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S10620-014-3284-2

Optimisation of circulating biomarkers of cell death for routine clinical use.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S10620-014-3284-2

The human glutathione S-transferases. Immunohistochemical studies of the developmental expression of Alpha- and Pi-class isoenzymes in liver

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S10620-014-3284-2

Apoptosis-induced acetylation of histones is pathogenic in systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S10620-014-3284-2

Increased serum levels of soluble CD95 (APO-1/Fas) in relapsing-remitting multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S10620-014-3284-2

Apoptosis of biliary epithelial cells in primary biliary cirrhosis and primary sclerosing cholangitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S10620-014-3284-2

First clinical trial of a novel caspase inhibitor: anti-apoptotic caspase inhibitor, IDN-6556, improves liver enzymes.

21 January 2018

1 reference

12 December 2020

Serum levels of soluble Fas/APO-1 (CD95) and its molecular structure in patients with systemic lupus erythematosus (SLE) and other autoimmune diseases

1 reference

12 December 2020

Soluble intracellular adhesion molecule, M30 and M65 as serum markers of disease activity and prognosis in cholestatic liver diseases

1 reference

12 December 2020

Significant role of apoptosis in type-1 autoimmune hepatitis

1 reference

12 December 2020

The inhibitors of apoptosis (IAPs) and their emerging role in cancer

1 reference

12 December 2020

Kupffer cell engulfment of apoptotic bodies stimulates death ligand and cytokine expression

1 reference

12 December 2020

A functional Fas promoter polymorphism is associated with a severe phenotype in type 1 autoimmune hepatitis characterized by early development of cirrhosis

1 reference

12 December 2020

Serum soluble Fas/APO-1 is increased in patients with primary Sjögren's syndrome

1 reference

12 December 2020

Increase in CD95 (Fas/APO-1)-positive CD4 and CD8 T cells in peripheral blood derived from patients with autoimmune hepatitis or chronic hepatitis C with autoimmune phenomena

1 reference

12 December 2020

Circulating soluble Fas concentration in breast cancer patients

1 reference

12 December 2020

Apoptosis and hepatobiliary disease

1 reference

12 December 2020

Markers of cell activation and apoptosis in bone marrow mononuclear cells of patients with autoimmune hepatitis type 1 and primary biliary cirrhosis

1 reference

12 December 2020

Apoptotic body engulfment by a human stellate cell line is profibrogenic.

1 reference

12 December 2020

Characterization of the caspase inhibitor IDN-1965 in a model of apoptosis-associated liver injury.

1 reference

12 December 2020

The apoptosis endonuclease and its regulation

1 reference

12 December 2020

Apoptotic U1-70 kd is antigenically distinct from the intact form of the U1-70-kd molecule

1 reference

12 December 2020

X-linked inhibitor of apoptosis regulates T cell effector function

1 reference

12 December 2020

Elevated soluble Fas (sFas) levels in nonhematopoietic human malignancy

1 reference

12 December 2020

Targeted mutation in the Fas gene causes hyperplasia in peripheral lymphoid organs and liver

1 reference

12 December 2020

Antisense oligonucleotides targeting XIAP induce apoptosis and enhance chemotherapeutic activity against human lung cancer cells in vitro and in vivo.

1 reference

12 December 2020

c-FLIP, a master anti-apoptotic regulator

1 reference

12 December 2020

Loss of TRAIL-R does not affect thymic or intestinal tumor development in p53 and adenomatous polyposis coli mutant mice

1 reference

12 December 2020

Soluble NKG2D ligands in hepatic autoimmune diseases and in benign diseases involved in marker metabolism

1 reference

12 December 2020

Mapping MHC-encoded susceptibility and resistance in primary sclerosing cholangitis: the role of MICA polymorphism

1 reference

12 December 2020

Apoptosis in liver diseases--detection and therapeutic applications.

1 reference

12 December 2020

Serum levels of soluble major histocompatibility complex (MHC) class I-related chain A in patients with chronic liver diseases and changes during transcatheter arterial embolization for hepatocellular carcinoma

1 reference

12 December 2020

Clinical Trial of the Pan-Caspase Inhibitor, IDN-6556, in Human Liver Preservation Injury

1 reference

12 December 2020

Increased soluble CD95 (sFas/CD95) serum level correlates with poor prognosis in melanoma patients

1 reference

12 December 2020

Detection of elevated caspase activation and early apoptosis in liver diseases

1 reference

12 December 2020

Apoptosis and autoimmune disease.

1 reference

12 December 2020

10.1007/S10620-014-3284-2

Identifiers

DOI

1 reference

Dimensions Publication ID

31 August 2017

1016765415

0 references

1 reference